The myocardial clearance of rubidium may be obtained by praecordial counting after intravenous injection of Rb86 Cl. Eight patients with recent myocardial infarction had this determination performed before and after the infusion of 1O mg phentolamine at a rate of 0.3 mg/minute. The reduction in the myocardial oxygen requirements may improve flow to the ischaemic area of the endocardium by favourably altering intramyocardial pressure, and hence the distribution of blood flow across the myocardium (Fortuin et al., I97I). In order to answer this unresolved question, the effect of phentolamine on the coronary blood flow in patients with a recent myocardial infarction has been studied.
The systemic arterial pressure is frequently raised during the course of a myocardial infarction. A reduction of the raised blood pressure should decrease the myocardial oxygen consumption requirements, and might limit the extent of the infarct and improve cardiac performance (Maroko et al., I97I) . Based on these concepts, phentolamine has been administered to patients with an acute myocardial infarct (Kelly et al., I973) . A reduction of the raised systemic arterial pressure has led to a fall in the ventricular end-diastolic pressure and a rise in the cardiac output.
The reduction in the myocardial oxygen requirements may improve flow to the ischaemic area of the endocardium by favourably altering intramyocardial pressure, and hence the distribution of blood flow across the myocardium (Fortuin et al., I97I) . In order to answer this unresolved question, the effect of phentolamine on the coronary blood flow in patients with a recent myocardial infarction has been studied.
Methods
The praecordial counting was performed with a 5 x 5 cm NaI(Ti) scintillation detector with a lead collimator, 150 mm long with an external diameter IIO mm. Pulses from the detector were fed via a pulse height analyser to a digital ratemeter and then to a recorder. For 131I activity the pulse height analyser was set for the 364 KeV photopeak with a I00 KeV window. For 86Rb, the pulse height analyser was set for i.o8 MeV with a I00 KeV window. The ratemeter time constant was set at 4 seconds for recording background and at 4 seconds during the procedures. The chart speed was set at 3 cm Received 9 October I974. per minute. Blood activity was measured in a 5 cm welltype scintillation detector with the pulse height analyser setting as described for external counting of 131I and 86Rb.
The counts are corrected for the relative inefficiencies in the in vivo and in vitro systems, introducing a coefficient ni calculated from the counting rates obtained when two 500-ml flasks containing known concentrations of 131I and 86Rb are counted externally under a standard geometrical arrangement.
-(c.p.m.fml) 131I (well) The experiments were performed in the morning on resting subjects in the supine position. A Cournand cannula was introduced into the right brachial artery. The detector was positioned over the centre of the heart silhouette.
I5tL Ci 131I as RIHSA, in 0.5 to i ml saline, was then rapidly injected into the left cubital vein. Thirty seconds after the injection the praecordial counting and arterial blood sampling were started; both counting and blood sampling lasted 3 minutes and the rate of withdrawal was i ml every 4 seconds. Within 5 minutes, 150 [t Ci 86Rb as rubidium chloride in o.s to i ml saline was rapidly injected into a cubital vein. Praecordial counts and arterial blood were taken as after the RIHSA injection. Recording was continued until blood sampling and praecordial counting were completed. Ten milligrams of phentolamine was then infused at a rate of 0.3 mg/min. At the conclusion of the infusion, the radioisotope studies, using 13'I and 86Rb, were repeated as described above. Care was taken to maintain the detector in the same position.
All the blood samples were haemolysed and counted in duplicate. The n coefficient was periodically measured to check the constancy of the conditions of the counting apparatus.
The blood pressure and cardiac rate were obtained before and after the phentolamine infusion. was performed an average of io days after the acute myocardial infarction. The clinical information on the entire group is listed in the Table. The procedure was explained in detail to the subjects and the investigative nature of the study was stressed. An informed consent was then obtained from all the subjects.
Calculations

Results
Complete data on the 8 patients are presented in the Table. The average value of the myocardial fraction of the praecordial counting rate (F) in the subjects studied with 86Rb was 69.5 ± 8.i per cent. The myocardial clearance of rubidium averaged 89.3 + 29.9 ml/min per IOO g of myocardium.
Effect of phentolamine In all of the 8 cases, the myocardial clearance increased after phentolamine. The rise ranged from II.O to 6o.o ml/min per Ioo g myocardium. The average change in the group amounted to 28 ml/min per ioo g, which was statistically significant (P < o.oi). Phentolamine produced a small but significant fall in the diastolic blood pressure and a significant increase in the cardiac rate.
Two isotopes are required in this method. The praecordial counting rate of the nondiffusible indicator RIHSA is related to the radioactive concentration in blood. On the other hand, after the intravenous injection of 86Rb the praecordial activity is made up of an intravascular and an extravascular component. The latter is mainly caused by myocardial activity. Subtraction of the intraventricular activity from the intravascular and myocardial activity will give only the myocardial activity. Donato et al. (I966) , in their recent publication, have described the measurement of coronary blood flow by external counting using radioactive rubidium. However, the absolute flow cannot be determined with this method since individual variability in depth and size of the heart prevents an absolute estimate of myocardial uptake of the radioisotope. The obtained value for myocardial clearance of rubidium represents the mean flow per unit mass, and it is conveniently expressed per Ioo g myocardium.
Discussion
A major advantage of this technique is the avoidance of coronary sinus catheterization which enhances the practical value of this method. Further, the entire measurement may be completed in go seconds, which is an obvious advantage compared to the indirect Fick technique which uses N20, inert The main limitation of the method stems from dosimetric limitation. The small percentage of gamma radiations emitted by 86Rb demands the use of relatively large radioactive doses which limit the number of measurements that may be performed in the individual patient to a maximum of two.
Coronary blood flow measured by the 86Rb method is reliable and reproducible. Donato measured coronary blood flow in the same patient with the N20 saturation method as well as the 86Rb external counting method. The average coronary blood flow values in the ii subjects using the N20 method was 72.0 ± i6.8 (SD) ml/min per I00 g myocardium, and in the same group using the 86Rb method was 68.6 ± i6.I (SD) ml/min per Ioo g myocardium. Further, the rubidium clearance values reported by Donato in his normal subjects and his stable coronary heart disease patients were similar to the values found in our laboratory (Gould et al., 1972) .
In our present study, every patient responded to the phentolamine infusion with a significant increase in the myocardial clearance of rubidium. This was associated with a small but significant decline in the diastolic blood pressure and a significant small rise in the cardiac rate. Kelly et al. (1973) have recently observed that phentolamine administration produced, in hypertensive patients with a recent myocardial infarction, a significant reduction in the left ventricular filling pressure and a rise in the cardiac index. This improvement in cardiac function was accomplished with only a minimal reduction in the systemic arterial pressure. Similarly, comparable haemodynamic improvement can be achieved with a phentolamine infusion in normotensive or hypotensive patients with an acute myocardial infarction (Gould et al., I974) . It had previously been demonstrated that an infusion of phentolamine is an effective treatment of congestive heart failure (Gould, Zahir, and Ettinger, I969; Majid, Sharma, and Taylor, I97I; Gould et al., I970a) or pulmonary oedema (Gould et al., 1970b) It has been recently demonstrated that phentolamine has beta-adrenergic stimulating properties as well as alpha-adrenergic blocking effects. This beta-adrenergic stimulating action is suggested by the observation that the fall in blood pressure and the increase in cardiac rate produced by 5 mg phentolamine can be significantly blocked by the prior administration of propranolol (Zahir and Gould, I97I) . Propranolol can similarly block the inotropic and chronotropic action of phentolamine in dogs (Singh, Hood, and Abelmann, I970) . The drug also has a peripheral vasodilating effect which is not blocked by atropine (Goodman and Gilman, I955) . Taylor et al. (I965) believe that a direct relaxing effect on the vascular smooth muscle plays the dominant role in the production of the conspicuous peripheral vasodilatation. However, the recently described beta-adrenergic stimulating action of phentolamine probably also contributes to the peripheral vasodilatation.
The various factors that influence myocardial oxygen consumption have recently been delineated (Sonnenblick, Ross, and Braunwald, I968) . The increased velocity of contraction, and the improvement in contractility produced by phentolamine (Gould et 
